23.06.2025 • TopicsInterviewECHAClimate protection

The Discussions are Constructive

The official meetings on the PFAS restriction proposal in the EU are making progress.

Two and a half years ago, five EU countries proposed to the European Chemicals Agency (ECHA) to regulate all per- and polyfluoroalkyl substances (PFASs) in the EU, including fluoropolymers. Juliane Glüge says that it is not yet clear when and in what form the restriction can be expected. As a representative of the European Chemical Society, she has been an observer in the ECHA committees discussing the restriction proposal and derogations from the outset.
She has now stepped down from this position for professional reasons. In the CHEManager interview with Uta Neubauer, she draws a positive interim conclusion.

Interview with Juliane Glüge, formerly ETH Zürich

Juliane presenting at a conference.
Juliane Glüge researched PFASs at ETH Zurich until the end of May. Until recently, she represented the European Chemical Society in the ECHA committee meetings on the planned PFAS restriction.
© Nadine Zielinski, Hightech Zentrum Aargau AG

CHEManager: The process initiated in the EU to regulate the entire PFAS class is running slowly. Are you frustrated that the process is taking so long?

Juliane Glüge: I am rather positive, because the way the proposal has been discussed so far is going in the right direction. The two ECHA committees [see infobox, page 9] are looking at the problem rationally, both in terms of the impact on the environment and the consequences for European competitiveness. The complexity of the problem and the amount of data require a certain amount of time.

For some use sectors - including cosmetics, ski wax and textiles - there are already preliminary opinions from the ECHA committees. What derogations are on the horizon?

J. Glüge: Unfortunately, I am not allowed to comment on specific derogations. What I can say, however, is that a third restriction option is currently being evaluated for some sectors. The first option is a total ban on all PFASs. The second option, which has been favoured so far, proposes derogations for certain uses, mostly limited in time. The third option, which is now also being examined in some cases, is about preventing emissions instead of banning PFASs completely in certain uses.

Is this new option an alternative to a ban?

J. Glüge: Yes, at least in some cases. This third option could be used if the socio-economic impact of banning a particular PFAS use is disproportionate, for example because there will be no technical alternative in the foreseeable future. Certain conditions would then have to be met in order to avoid emissions.

Read more with free registration

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Sign in or register

Company

Logo:

CHEManager International c/o Wiley-VCH GmbH

Boschstrasse 12
69469 Weinheim
Germany

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.